Lixte Biotechnology Holdings
We have no price for Lixte Biotechnology Holdings since 28 August 2026. It may have been taken over, merged or renamed, so the figures below are from then.
Trading in the middle of its range for the past year.
The essentials
Four questions every investor asks, answered in one line each.
We do not have this company's yearly figures yet, so its profit, growth, price and debt cannot be judged here.
Money in, money out
What Lixte Biotechnology Holdings sold, what it kept, and what it did with the cash.
Sales went from $0 in 2022 to $0 in 2025, with -$6.01 million of profit last year.
Lixte Biotechnology Holdings vs. similar companies
How it compares with the largest companies in its industry.
| Company | Profit from $100 of sales | Sales growth a year | Price per $1 of profit |
|---|---|---|---|
| Lixte Biotechnology Holdings | No profit yet | ||
 Vertex Pharmaceuticals | 35.1× · Expensive | ||
 Moderna | No profit yet | ||
 Regeneron Pharmaceuticals | 22.0× · Fair price | ||
 CSL | 22.1× · Fair price |
AI analysis
An AI analyst reads Lixte Biotechnology Holdings's last five years, its segments, earnings, insiders and peers, and writes the bull case, the bear case and what the price expects.
Run the AI analysisFull statementsIncome, balance sheet and cash flow, year by year
Income statement
| In millions of USD | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|
| 0 | 0 | 0 | 0 | |
| – | – | – | – | |
| -6 | -5 | -4 | -5 | |
| -6 | -5 | -4 | -6 | |
| -6 | -5 | -4 | -6 | |
| -3.99 | -2.66 | -1.59 | -1.26 | |
| – | – | – | – | |
| – | – | – | – | |
| – | – | – | – |
Balance sheet
| In millions of USD | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|
| Total assets | 6 | 4 | 1 | 13 |
| Cash | 5 | 4 | 1 | 5 |
| Total debt | – | – | 0 | 1 |
| Total liabilities | 0 | 0 | 0 | 2 |
| 5 | 4 | 1 | 10 | |
| 2 | 2 | 2 | 5 | |
| -96.4% | -100.3% | -340.9% | -45.9% | |
| -122.2% | -127.3% | -433.5% | -62.2% |
Cash flow
| In millions of USD | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|
| -5 | -4 | -3 | -3 | |
| – | – | – | – | |
| -5 | -4 | -3 | -3 | |
| Dividends paid | – | – | – | – |
| – | – | – | – | |
| 2 | 1 | 0 | 2 |
Valuation
- –
- –
- –
- –
- –
- –
- –
- –
- –
- –
Profitability
- –
- –
- –
- –
- –
- –
- –
- –
- –
- –
Growth
- –
- –
- –
- –
- –
Financial health
- –
- –
- –
- –
- –
- –
- –
Recent earnings
Our results feed has not updated since May 21, 2026. Results reported after that are not in this table yet.
| Date | EPS | Expected | Surprise |
|---|---|---|---|
| May 14, 2026 | -0.18 | – | – |
| Mar 31, 2026 | -0.33 | – | – |
| Nov 12, 2025 | -0.33 | – | – |
| Aug 7, 2025 | -0.29 | – | – |
| May 12, 2025 | -0.29 | – | – |
| Mar 24, 2025 | -0.27 | – | – |
| Nov 12, 2024 | -0.44 | – | – |
| Aug 8, 2024 | -0.45 | – | – |
News
No recent news on file.
Insider trades
Our insider feed has not updated since May 26, 2026. Trades filed after that are not listed yet.
No insider trades on file.
The seven classic investing rulebooks
0/7Passes 0 of 7. Each bar is how well the company fits that investor's published rules, from 0 to 100; 60 or more counts as a pass.
Questions about Lixte Biotechnology Holdings
Is Lixte Biotechnology Holdings a good stock to buy?
We do not have this company's yearly figures yet, so its profit, growth, price and debt cannot be judged here. 0 of the 7 famous investors' published rulebooks we apply pass it. Whether it suits you depends on your goals and the price you pay; invest-like never tells anyone to buy or sell. The AI analysis lays out the case for and against. Read the Lixte Biotechnology Holdings AI analysis
What does Lixte Biotechnology Holdings do?
Lixte Biotechnology Holdings, Inc. is a drug discovery company focused on developing new treatments. It employs biomarker technology to identify crucial enzyme targets associated with serious, widespread diseases, then designs innovative compounds to act upon these targets. It is in Biotechnology.
Does Lixte Biotechnology Holdings pay a dividend?
No. Lixte Biotechnology Holdings does not pay a dividend at the moment.
Who are Lixte Biotechnology Holdings's competitors?
The largest listed companies in the same industry are Vertex Pharmaceuticals, Moderna, Regeneron Pharmaceuticals and CSL. The peers table on this page compares their profit, growth and price with Lixte Biotechnology Holdings's.
Prices: daily closes to Aug 28, 2026. Fundamentals: company reports via invest-like data.